SCHEMBL1821828

SCHEMBL1821828

CCOC(=O)C(c1cccc(OS(=O)(=O)c2ccc(C)cc2)c1)C(N)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 6/20 0.41
PLAU P00749 1/20 0.40
PLAT P00750 1/20 0.40
GAA P10253 3/20 0.39
MAPT P10636 1/20 0.39
G6PD P11413 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GPR17 Q13304 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3570917 0.95 SMN1; SMN2 (0.40) GAAALDH1A1TP53MAPK1TDP1
SCHEMBL1822845 0.93 P2RX7 (0.46) P2RX7PLAUPLATMAPTPOLB
SCHEMBL1829278 0.92 PLAU (0.46) P2RX7PLAUPLATGAAMAPT
SCHEMBL1825726 0.90 PLAU (0.42) P2RX7PLAUPLATGAAMAPT
SCHEMBL1823187 0.90 P2RX7 (0.45) P2RX7MAPTALDH1A1POLBMEN1
SCHEMBL1827267 0.89 P2RX7 (0.46) P2RX7PLAUPLATGAAMAPT
SCHEMBL1825023 0.87 P2RX7 (0.40) P2RX7PLAUPLATGAAMAPT
SCHEMBL1824851 0.86 PPARG (0.41) ALDH1A1TP53KMT2A
SCHEMBL1823534 0.86 P2RX7 (0.43) P2RX7GAAMAPTG6PDNPSR1
SCHEMBL1823156 0.85 LTA4H (0.44) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 P2RX7 3606/4885PLAU 4857/4885PLAT 4864/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 P2RX7 2747/4885PLAU 4788/4885PLAT 4392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.